Clareon™ PanOptix™ Trifocal Hydrophobic IOL - ARCSA Registration 6bf826d1a3a63d107c2c745bc20f35f9
Access comprehensive regulatory information for Clareon™ PanOptix™ Trifocal Hydrophobic IOL in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 6bf826d1a3a63d107c2c745bc20f35f9 and manufactured by ALCON LABORATORIES IRELAND LTD.. The device was registered on September 17, 2021.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
THE CLAREON™ PANOPTIX™ TRIFOCAL LIO IS DESIGNED TO BE IMPLANTED IN THE CAPSULAR SAC OF THE POSTERIOR CHAMBER OF THE EYE, REPLACING THE HUMAN LENS. THIS POSITION OF THE LENS ALLOWS THE LIO TO ACT AS A REFRACTIVE MEDIUM IN APHAKIA CORRECTION.

